NIGMS Payline

NIGMS — the National Institute of General Medical Sciences, one of NIH’s 27 institutes and centers — is notable among NIH institutes for not publishing a traditional percentile-rank payline the way NINDS, NHLBI, and NIAID do. NIGMS has long described its funding decisions as based on a combination of an application’s percentile score, program relevance, and portfolio considerations — including whether an investigator already holds substantial other NIH support — rather than a single published percentile cutoff below which applications are funded and above which they are not. Understanding ‘NIGMS payline’ means understanding this distinctive, more holistic approach, not looking up a single number the way one might for a payline institute.

Why NIGMS doesn’t publish a conventional payline

Most NIH institutes set an annual percentile threshold, per grant mechanism, as a public planning guideline — see CASRAI’s general NIH Payline entry for how that mechanism works institute by institute. NIGMS has instead historically stated that even an application with an excellent percentile score is not guaranteed funding if, for example, the investigator’s lab already carries substantial other NIH support, and that applications outside a strong percentile range can still be funded where program priorities and portfolio balance justify it. This reflects NIGMS’s stated funding philosophy of considering the overall research portfolio it supports — across investigators, institutions, and scientific areas — rather than ranking applications strictly by score within a fixed cutoff.

How NIGMS decides funding without a published cutoff

After peer review at an NIH study section, a NIGMS application still receives an impact score and percentile rank, exactly as it would at any other NIH institute — NIGMS does not skip peer review or scoring. What differs is what NIGMS does with that percentile afterward: rather than publishing a fixed threshold that applicants can check against, NIGMS states that funding decisions weigh the percentile alongside factors such as the applicant’s current level of NIH support, the scientific and programmatic balance of NIGMS’s overall funded portfolio, and alignment with the institute’s mission areas. NIGMS retains the same general discretionary mechanisms other institutes use — advisory council review and program-priority funding — but does not attach them to a public payline figure the way NINDS, NHLBI, and NIAID do.

MIRA (R35): NIGMS’s flagship award, and why it complicates payline framing further

NIGMS’s Maximizing Investigators’ Research Award (MIRA, activity code R35) adds a further reason a simple payline doesn’t map cleanly onto NIGMS funding. MIRA consolidates the research support NIGMS provides to a single investigator’s overall research program into one award, rather than funding separate individual project grants (such as multiple R01s) for that investigator. Because MIRA review evaluates an investigator’s overall research program, productivity, and approach rather than the specific-aims structure of a single proposed project, and because eligibility and review criteria for MIRA differ from a standard R01, a percentile-based payline concept — built around ranking individual project applications against each other — fits MIRA’s review model even less naturally than it fits NIGMS’s R01 funding generally. NIGMS runs MIRA tracks for both established investigators and early-stage investigators, with reported historical success rates that have varied by track and fiscal year; treat any specific percentage as a historical data point to confirm against NIGMS’s current published statistics rather than an ongoing guarantee, since success rates move with appropriation and applicant volume each year.

NIGMS payline vs. NHLBI, NINDS, and NIAID paylines

‘NIGMS payline,’ ‘NHLBI payline,’ ‘NINDS payline,’ and ‘NIAID payline’ are sometimes used as if they were interchangeable institute-specific versions of the same published figure. They are not directly comparable. NHLBI, NINDS, and NIAID each publish an explicit percentile threshold per fiscal year and mechanism — see CASRAI’s NHLBI Payline guide, NINDS Payline, and NIAID Payline entries for how each does this. NIGMS does not publish an equivalent single number for R01s, and its flagship MIRA mechanism reviews investigators’ overall programs rather than individual projects. A research administrator moving between institute portfolios should not assume NIGMS applies, or even could apply, the same payline logic as these other institutes — asking a NIGMS program officer directly about funding likelihood for a specific application is the more reliable approach than looking for a published NIGMS percentile figure.

NIH’s November 2025 shift: the field moving toward NIGMS’s approach

In a November 2025 announcement on its Extramural Nexus News page, NIH stated that its institutes and centers ‘will not rely on funding paylines in developing pay plans’ going forward, signaling a shift across NIH toward weighing peer-review scores against institute priorities, strategic plans, and budget more holistically, rather than publishing a fixed percentile cutoff. Sourcing note: the primary grants.nih.gov page describing this change returned an access error on direct verification for this entry; the substance is corroborated by independent secondary coverage quoting the same NIH language, consistent with how CASRAI has sourced this policy signal in its NIH Payline, NINDS Payline, and NIAID Payline entries — treat as REPORTED-tier and confirm current institute-by-institute practice directly. Notably, this NIH-wide shift moves other institutes toward an approach NIGMS has used for years — weighing percentile alongside portfolio and program considerations rather than a strict published cutoff — rather than requiring any real change in how NIGMS itself operates. See CASRAI’s NIH Payline entry for this policy signal in fuller context.

Frequently asked questions

Does NIGMS have a payline?

Not in the sense that NINDS, NHLBI, and NIAID have one. NIGMS does not publish a fixed percentile-rank cutoff for R01 or other standard grant mechanisms; it has instead described funding decisions as weighing an application’s percentile score alongside factors like the investigator’s current NIH support level and the balance of NIGMS’s overall funded portfolio.

If NIGMS doesn’t publish a payline, how do I estimate my odds of funding?

Because NIGMS does not publish a single comparable figure, applicants and research administrators typically rely on NIGMS’s published success-rate and funding-trend data, the applicant’s own percentile score and its position relative to recently funded NIGMS awards in the same mechanism, and direct conversation with the assigned NIGMS program officer, rather than checking a published cutoff the way one would for NHLBI or NINDS.

Does MIRA (R35) have its own NIGMS payline?

No. MIRA review evaluates an investigator’s overall research program rather than ranking individual project applications against a percentile cutoff, so the payline concept — built around ranking discrete project applications — does not map onto MIRA the way it does onto a standard R01 competition.

Is NIGMS’s approach related to NIH’s November 2025 policy shift away from paylines?

They are related in direction but not identical in origin. NIGMS’s portfolio-based approach predates the November 2025 announcement by years; the November 2025 shift is NIH moving its payline-publishing institutes toward a more holistic approach broadly similar in spirit to what NIGMS has already used, not NIGMS itself changing practice in response to that announcement.

Where can I find NIGMS’s current funding policies?

Check NIGMS’s own current grant-application and post-award funding-policy guidance directly (nigms.nih.gov), since institute practice can be revised, and confirm specifics with the NIGMS program officer assigned to a specific application rather than relying on a previously cited figure or general description.